| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
21,890,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Pasithea Therapeutics is a biotechnology company focused on the research and discovery of treatments for psychiatric and neurological disorders. Co.'s secondary operations focus on establishing anti-depression clinics across the U.K. and providing business support services to similar entities in the U.S., using trained pharmacists to administer intravenous infusions of ketamine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
30,000 |
417,503 |
| Total Buy Value |
$0 |
$0 |
$12,930 |
$476,221 |
| Total People Bought |
0 |
0 |
1 |
4 |
| Total Buy Transactions |
0 |
0 |
1 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Steinman Lawrence |
Director |
– • – |
2023-06-02 |
4 |
B |
$0.43 |
$12,930 |
D/D |
30,000 |
1,327,174 |
2.39 |
- |
|
| Steinman Lawrence |
Director |
– • – |
2022-11-28 |
4 |
A |
$0.98 |
$4,900 |
D/D |
5,000 |
1,287,174 |
|
- |
|
| Marques Tiago |
Chief Executive Officer |
• • – |
2022-11-25 |
4 |
A |
$1.03 |
$2,060 |
D/D |
2,000 |
819,206 |
|
- |
|
| Marques Tiago |
Chief Executive Officer |
• • – |
2022-11-23 |
4 |
A |
$1.00 |
$7,260 |
D/D |
7,206 |
817,206 |
|
- |
|
| Steinman Lawrence |
Director |
– • – |
2022-11-22 |
4 |
A |
$0.99 |
$4,950 |
D/D |
5,000 |
1,282,174 |
|
- |
|
| Dumesnil Simon |
Director |
– • – |
2022-11-17 |
4 |
A |
$1.06 |
$42,400 |
D/D |
40,000 |
50,000 |
|
- |
|
| Dumesnil Simon |
Director |
– • – |
2022-11-15 |
4 |
A |
$1.07 |
$10,700 |
D/D |
10,000 |
10,000 |
|
- |
|
| Steinman Lawrence |
Director |
– • – |
2022-10-26 |
4 |
A |
$1.10 |
$5,500 |
D/D |
5,000 |
1,277,174 |
|
- |
|
| Tiger Lily Capital, Llc |
10% Owner |
– – • |
2022-10-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,608,696 |
|
- |
|
| Marques Tiago |
Chief Executive Officer |
• • – |
2022-10-21 |
4 |
A |
$1.07 |
$5,356 |
D/D |
5,000 |
810,000 |
|
- |
|
| Elderhill Corp |
Member of 10% owner group |
– – – |
2022-10-17 |
4 |
B |
$1.11 |
$1,110 |
I/I |
1,000 |
227,521 |
0.01 |
- |
|
| Steinman Lawrence |
Director |
– • – |
2022-10-17 |
4 |
A |
$1.13 |
$11,310 |
D/D |
10,000 |
1,272,174 |
|
- |
|
| Camac Partners, Llc |
Member of 10% owner group |
– – – |
2022-09-29 |
4 |
B |
$1.16 |
$7,757 |
I/I |
6,710 |
1,788,415 |
0.01 |
- |
|
| Camac Partners, Llc |
Member of 10% owner group |
– – – |
2022-09-28 |
4 |
B |
$1.19 |
$68,542 |
I/I |
57,647 |
1,781,705 |
0.01 |
- |
|
| Camac Partners, Llc |
Member of 10% owner group |
– – – |
2022-09-06 |
4 |
B |
$1.13 |
$24,632 |
I/I |
21,748 |
1,724,058 |
0.01 |
- |
|
| Camac Partners, Llc |
Member of 10% owner group |
– – – |
2022-09-02 |
4 |
B |
$1.14 |
$13,105 |
I/I |
11,507 |
1,702,310 |
0.01 |
- |
|
| Camac Partners, Llc |
Member of 10% owner group |
– – – |
2022-09-01 |
4 |
B |
$1.13 |
$62,630 |
I/I |
55,646 |
1,690,803 |
0.01 |
- |
|
| Camac Partners, Llc |
Member of 10% owner group |
– – – |
2022-08-30 |
4 |
B |
$1.15 |
$20,452 |
I/I |
17,828 |
1,635,157 |
0.01 |
- |
|
| Camac Partners, Llc |
Member of 10% owner group |
– – – |
2022-08-29 |
4 |
B |
$1.17 |
$5,841 |
I/I |
5,000 |
1,617,329 |
0.01 |
- |
|
| Leonite Capital Llc |
Member of 10% owner group |
– – – |
2022-08-19 |
4 |
B |
$1.30 |
$70,939 |
I/I |
54,644 |
54,644 |
0.01 |
- |
|
| Camac Partners, Llc |
Member of 10% owner group. |
– – – |
2022-08-17 |
4 |
B |
$1.21 |
$188,283 |
I/I |
155,773 |
1,611,329 |
0.01 |
- |
|
| Elderhill Corp |
|
– – – |
2022-08-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
226,521 |
|
- |
|
| Leonite Capital Llc |
10% Owner |
– – • |
2022-08-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,034,702 |
|
- |
|
| Steinman Lawrence |
Director |
– • – |
2022-06-29 |
4 |
A |
$1.00 |
$5,000 |
D/D |
5,000 |
1,272,174 |
|
- |
|
| Steinman Lawrence |
Director |
– • – |
2022-06-28 |
4 |
A |
$1.02 |
$5,100 |
D/D |
5,000 |
1,267,174 |
|
- |
|
36 Records found
|
|
Page 1 of 2 |
|
|
